Chen, M.-W.; Huang, Y.-R.; Lo, W.-L.; Lee, S.-Y.; Lo, S.-N.; Wang, S.-M.; Chang, K.-W.
PSMA-Targeted Radiolabeled Peptide for Imaging and Therapy in Prostate Cancer: Preclinical Evaluation of Biodistribution and Therapeutic Efficacy. Int. J. Mol. Sci. 2025, 26, 7580.
https://doi.org/10.3390/ijms26157580
AMA Style
Chen M-W, Huang Y-R, Lo W-L, Lee S-Y, Lo S-N, Wang S-M, Chang K-W.
PSMA-Targeted Radiolabeled Peptide for Imaging and Therapy in Prostate Cancer: Preclinical Evaluation of Biodistribution and Therapeutic Efficacy. International Journal of Molecular Sciences. 2025; 26(15):7580.
https://doi.org/10.3390/ijms26157580
Chicago/Turabian Style
Chen, Ming-Wei, Yuan-Ruei Huang, Wei-Lin Lo, Shih-Ying Lee, Sheng-Nan Lo, Shih-Ming Wang, and Kang-Wei Chang.
2025. "PSMA-Targeted Radiolabeled Peptide for Imaging and Therapy in Prostate Cancer: Preclinical Evaluation of Biodistribution and Therapeutic Efficacy" International Journal of Molecular Sciences 26, no. 15: 7580.
https://doi.org/10.3390/ijms26157580
APA Style
Chen, M.-W., Huang, Y.-R., Lo, W.-L., Lee, S.-Y., Lo, S.-N., Wang, S.-M., & Chang, K.-W.
(2025). PSMA-Targeted Radiolabeled Peptide for Imaging and Therapy in Prostate Cancer: Preclinical Evaluation of Biodistribution and Therapeutic Efficacy. International Journal of Molecular Sciences, 26(15), 7580.
https://doi.org/10.3390/ijms26157580